Depomed Targets Generics Maker Over Diabetes Drug IP
Pharmaceutical company Depomed Inc. filed a patent infringement suit Thursday in Delaware federal court against Watson Laboratories Inc., saying the company's planned generic version of Depomed's extended-release metformin drug Glumetza for...To view the full article, register now.
Already a subscriber? Click here to view full article